Contact this trialFirst, we need to learn more about you.
Anti-tumor antibiotic
Abiraterone Dosing for Prostate Cancer
Recruiting3 awardsPhase 1
Chicago, Illinois
This trial is studying the best dose of a prostate cancer drug, abiraterone acetate, for up to 12 weeks. Participants will decide how long to stay on the drug after. #medicine
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.